⌘K

Home/Filings/4/0001213900-26-002948

4//SEC Filing

KUCHARCHUK ANDREW ALBERT 4

Accession 0001213900-26-002948

CIK 0001870404other

View on SEC.gov Company Profile

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 4:30 PM ET

Size

5.4 KB

Accession

0001213900-26-002948

Insider Transaction Report

Form 4

Period: 2026-01-07

CERO THERAPEUTICS HOLDINGS, INC.CERO

KUCHARCHUK ANDREW ALBERT

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2026-01-07+1,162,099→ 1,162,099 total
Exercise: $0.06From: 2026-01-07Exp: 2036-01-06→ Common Stock (1,162,099 underlying)

Documents

1 file

4
ownership.xmlPrimary

Issuer

CERO THERAPEUTICS HOLDINGS, INC.

CIK 0001870404

Entity typeother

Related Parties

1

filerCIK 0001654127

Filing Metadata

Form type: 4
Filed: Jan 8, 7:00 PM ET
Accepted: Jan 9, 4:30 PM ET
Size: 5.4 KB

View on SEC.gov